胸苷酸合成酶基因在肿瘤发生发展中的研究进展  

Research progress of thymidylate synthase gene in tumorigenesis and development

作　　者：洪金全[1] 黄震宇 黄惠炆[3] 黄豪博[3] Hong Jinquan;Huang Zhenyu;Huang Huiwen;Huang Haobo(Department of Anesthesia,The Second Affiliated Hospital,Fujian Medical University,Quanzhou 362000,China;School of Food and Bioengineering,Fujian Polytechnic Normal University,Fuzhou 350300,China;Department of Blood Transfusion,Fujian Medical University Union Hospital,Fuzhou 350001,China)

机构地区：[1]福建医科大学附属第二医院麻醉科,泉州362000 [2]福建技术师范学院食品与生物工程学院,福州350300 [3]福建医科大学附属协和医院输血科,福州350001

出　　处：《国际医药卫生导报》2025年第8期1260-1265,共6页International Medicine and Health Guidance News

基　　金：福建省科技创新联合资金(2019Y9050)。

摘　　要：胸苷酸合成酶(thymidylatesynthase,TYMS)基因编码蛋白是DNA合成必需的限速酶,也是重要的DNA损伤修复酶,在多种生理病理情况下发挥重要作用。本文主要对TYMS基因在不同类型肿瘤中的表达和临床意义、对肿瘤细胞恶性生物学行为及化疗药物敏感性的影响和作用机制、调控DO1:10.376020241118-08007 TYMS基因表达的多种因子以及靶向TYMS基因的抗肿瘤应用进行综述。Protein encoded by the thymidylate synthase(TYMS)gene is a rate-limiting enzyme necessary for DNA synthesis and is an important enzyme for DNA damage repair,and plays an important role in a variety of physiological and pathological conditions.This article mainly reviews the expression and clinical significance of TYMS gene in various types of tumors,the effect and mechanism of TYMS gene on the malignant biological behaviors and the sensitivity to chemotherapeutic drugs of tumor cells,various factors regulating TYMS gene expression,and the anti-tumor application of TYMS gene targeting.

关 键 词：肿瘤 胸苷酸合成酶 发生 发展 机制 进展 

分 类 号：R730.2[医药卫生—肿瘤]